Skip to main content
. 2014 Jun 26;9(3):164–167. doi: 10.5114/pg.2014.43758

Table II.

Comparison of HBsAg levels among the END, lamivudine and tenofovir groups

Variable Lamivudine group (n = 30) Tenofovir group (n = 21) END group (n = 25) Value of p
HBsAg levels 6224 ±7996 3895 ±6300 8630 ±6562 < 0.01
HBsAg log 3.46 ±0.66 3.27 ±0.56 3.79 ±0.41 < 0.01
Age 46.6 ±13.7 50.0 ±11.1 39.3 ±10.8 < 0.01
Gender (F/M) 15/15 6/15 13/12 > 0.05
ALT [IU/ml] 26.0 ±12.0 26.1 ±8.4 89.0 ±123 < 0.0001